Upregulation of CacyBP/SIP has been found in some neurodegenerative disorders such as frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS) [24] or Huntington’s disease (HD) [25]. This evidence concerns the gene CACYBP and juvenile Huntington disease.